Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-14

Clinical Trial Update: Effects of Fenofibrate Therapy in Diabetic Nephropathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update examining the effects of fenofibrate therapy in diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Singapore General Hospital | Conditions: Diabetes Mellitus, Diabetic Nephropathies | Phase 3 | Status: UNKNOWN